Clinical Trial

Effect of Ipratropium Bromide on EILO

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The investigators propose a study that compares breathlessness and airway obstruction during intense exercise in 34 children and adolescents with Exercise-Induced Laryngeal Obstruction after breathing in ipratropium bromide or placebo. It is hypothesized that breathlessness and airway obstruction will be lower following breathing in ipratropium bromide compared with placebo.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2029-03-30 -> 2029-12-31 2026-05-06
minor Completion pushed: 2029-03-30 -> 2029-12-31 2026-05-06
Trial Details
NCT Number NCT07394036
Lead Sponsor Cook Children's Health Care System
Conditions Exercise-Induced Laryngeal Obstruction, Dyspnea During Activity
Enrollment 50 participants
Start Date 2026-06-01
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-05